Day One Biopharmaceuticals (DAWN) Short Interest Ratio & Short Volume → Write this ticker symbol down… (From StocksToTrade) (Ad) Free DAWN Stock Alerts $12.77 -0.11 (-0.85%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Day One Biopharmaceuticals Short Interest DataCurrent Short Interest10,600,000 sharesPrevious Short Interest11,190,000 sharesChange Vs. Previous Month-5.27%Dollar Volume Sold Short$174.05 millionShort Interest Ratio9.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares87,390,000 sharesFloat Size60,580,000 sharesShort Percent of Float17.50%Today's Trading Volume407,400 sharesAverage Trading Volume869,485 sharesToday's Volume Vs. Average47% Short Selling Day One Biopharmaceuticals ? Sign up to receive the latest short interest report for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDAWN Short Interest Over TimeDAWN Days to Cover Over TimeDAWN Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Day One Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202410,600,000 shares $174.05 million -5.3%17.5%9.7 $16.42 4/30/202411,190,000 shares $191.35 million +25.2%18.5%10.7 $17.10 4/15/20248,940,000 shares $123.82 million -0.5%15.2%10.6 $13.85 3/31/20248,980,000 shares $148.35 million -6.6%15.2%14.5 $16.52 3/15/20249,610,000 shares $138.29 million -0.9%16.3%16.6 $14.39 2/29/20249,700,000 shares $162.28 million -0.2%16.5%17.3 $16.73 Get the Latest News and Ratings for DAWN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20249,720,000 shares $149.30 million +6.2%16.6%19.5 $15.36 1/31/20249,150,000 shares $137.71 million -15.3%15.5%17.4 $15.05 1/15/202410,800,000 shares $150.55 million +0.5%19.1%16.7 $13.94 12/31/202310,750,000 shares $156.95 million -2.3%19.0%15.1 $14.60 12/15/202311,000,000 shares $156.86 million +2.3%19.4%14.8 $14.26 11/30/202310,750,000 shares $124.49 million -0.7%19.0%13 $11.58 11/15/202310,830,000 shares $130.72 million -8.5%19.2%13.1 $12.07 10/31/202311,840,000 shares $140.07 million +4.3%21.0%14.1 $11.83 10/15/202311,350,000 shares $125.64 million -7.8%20.1%14.7 $11.07 9/30/202312,310,000 shares $151.04 million -0.5%21.3%16.7 $12.27 9/15/202312,370,000 shares $172.19 million +2.7%21.4%16 $13.92 8/31/202312,050,000 shares $162.55 million -0.2%20.4%13.2 $13.49 8/15/202312,070,000 shares $166.32 million -12.4%20.4%10.3 $13.78 7/31/202313,780,000 shares $182.45 million +1.0%30.1%11.5 $13.24 7/15/202313,640,000 shares $158.91 million -2.4%29.8%10.7 $11.65 6/30/202313,980,000 shares $166.92 million +3.5%30.6%11 $11.94 6/15/202313,510,000 shares $177.52 million +35.1%29.6%10.1 $13.14 5/31/202310,000,000 shares $133 million +7.2%21.5%8.8 $13.30 5/15/20239,330,000 shares $129.50 million +2.3%20.1%11.3 $13.88 4/30/20239,120,000 shares $113.09 million +16.0%20.0%11.7 $12.40 4/15/20237,860,000 shares $96.99 million +6.1%17.3%11.6 $12.34 3/31/20237,410,000 shares $99.07 million +11.3%16.3%10.7 $13.37 3/15/20236,660,000 shares $124.34 million +12.1%14.6%12.1 $18.67 2/28/20235,940,000 shares $109.41 million +4.4%13.0%10.7 $18.42 2/15/20235,690,000 shares $111.18 million +6.6%12.5%10.7 $19.54 1/31/20235,340,000 shares $116.25 million -4.5%11.6%10.1 $21.77 1/15/20235,590,000 shares $127.62 million +25.1%14.0%10.5 $22.83 12/30/20224,470,000 shares $96.19 million +3.5%11.2%8.4 $21.52 12/15/20224,320,000 shares $92.53 million -1.1%11.0%8.6 $21.42 11/30/20224,370,000 shares $92.78 million -4.2%11.1%7.3 $21.23 11/15/20224,560,000 shares $99.82 million -9.5%11.6%7.5 $21.89 10/31/20225,040,000 shares $106.55 million -7.9%12.7%7.7 $21.14 10/15/20225,470,000 shares $114.21 million -8.5%14.6%8.5 $20.88 9/30/20225,980,000 shares $119.78 million -3.1%17.0%9.5 $20.03Write this ticker symbol down… (Ad)A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution 9/15/20226,170,000 shares $140.55 million -9.3%17.5%9 $22.78 8/31/20226,800,000 shares $159.73 million -6.7%21.3%4 $23.49 8/15/20227,290,000 shares $182.25 million -0.7%22.9%4.2 $25.00 7/31/20227,340,000 shares $125.73 million -6.0%24.3%4.4 $17.13 7/15/20227,810,000 shares $149.48 million +8.2%25.8%4.8 $19.14 6/30/20227,220,000 shares $129.24 million +0.6%23.2%4.5 $17.90 6/15/20227,180,000 shares $109.50 million +37.3%28.1%4.8 $15.25 5/31/20225,230,000 shares $32.53 million +9.2%23.8%17.8 $6.22 5/15/20224,790,000 shares $36.64 million +11.1%21.8%21.1 $7.65 4/30/20224,310,000 shares $36.72 million +6.4%19.8%20.2 $8.52 4/15/20224,050,000 shares $45.85 million +2.3%18.6%18.6 $11.32 3/31/20223,960,000 shares $39.28 million +0.5%N/A16.7 $9.92 3/15/20223,940,000 shares $41.29 million -1.3%18.1%16.1 $10.48 2/28/20223,990,000 shares $54.50 million +0.8%18.4%15.1 $13.66 2/15/20223,960,000 shares $54.61 million +4.8%18.2%14.6 $13.79 1/31/20223,780,000 shares $55.76 million +11.2%17.2%15.3 $14.75 1/15/20223,400,000 shares $47.91 million -1.2%N/A15.3 $14.09 12/31/20213,440,000 shares $57.96 million +30.3%14.8%18.7 $16.85 12/15/20212,640,000 shares $48.18 million +38.2%11.4%16 $18.25 11/30/20211,910,000 shares $35.09 million +6.1%8.8%16.2 $18.37 11/15/20211,800,000 shares $38.27 million -3.7%8.6%19.1 $21.26 10/29/20211,870,000 shares $45.70 million +1.6%8.9%17.7 $24.44 10/15/20211,840,000 shares $40.76 million +3.4%8.8%17.1 $22.15 9/30/20211,780,000 shares $42.24 million +6.6%8.5%16.2 $23.73 9/15/20211,670,000 shares $41.63 million +7.7%8.0%14.9 $24.93 8/31/20211,550,000 shares $43.14 million +22.1%7.8%19 $27.83 8/13/20211,270,000 shares $31.17 million No Change6.4%8.8 $24.54 DAWN Short Interest - Frequently Asked Questions What is Day One Biopharmaceuticals' current short interest? Short interest is the volume of Day One Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 10,600,000 shares of DAWN short. 17.50% of Day One Biopharmaceuticals' shares are currently sold short. Learn More on Day One Biopharmaceuticals' current short interest. What is a good short interest ratio for Day One Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DAWN shares currently have a short interest ratio of 10.0. Learn More on Day One Biopharmaceuticals's short interest ratio. Which institutional investors are shorting Day One Biopharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Day One Biopharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Day One Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.50% of Day One Biopharmaceuticals' floating shares are currently sold short. Is Day One Biopharmaceuticals' short interest increasing or decreasing? Day One Biopharmaceuticals saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 10,600,000 shares, a decrease of 5.3% from the previous total of 11,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Day One Biopharmaceuticals' float size? Day One Biopharmaceuticals currently has issued a total of 87,390,000 shares. Some of Day One Biopharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Day One Biopharmaceuticals currently has a public float of 60,580,000 shares. How does Day One Biopharmaceuticals' short interest compare to its competitors? 17.50% of Day One Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Day One Biopharmaceuticals: MannKind Co. (13.13%), Arcutis Biotherapeutics, Inc. (19.15%), Castle Biosciences, Inc. (4.67%), LeMaitre Vascular, Inc. (4.21%), Black Diamond Therapeutics, Inc. (3.80%), Atai Life Sciences (5.25%), Design Therapeutics, Inc. (8.59%), Kinnate Biopharma Inc. (2.01%), Sangamo Therapeutics, Inc. (7.10%), Burning Rock Biotech Limited (0.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Day One Biopharmaceuticals stock? Short selling DAWN is an investing strategy that aims to generate trading profit from Day One Biopharmaceuticals as its price is falling. DAWN shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Day One Biopharmaceuticals? A short squeeze for Day One Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DAWN, which in turn drives the price of the stock up even further. How often is Day One Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DAWN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MNKD Short Interest ARQT Short Interest CSTL Short Interest LMAT Short Interest BDTX Short Interest ATAI Short Interest DSGN Short Interest KNTE Short Interest SGMO Short Interest BNR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DAWN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Day One Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.